Gansu Longshenrongfa Pharmaceutical (300534.SZ) Obtains Medical Device Registration Certificate for Hemodialysis Concentrate

Stock News

11/28

Gansu Longshenrongfa Pharmaceutical (300534.SZ) announced that on November 28, 2025, the company received the Medical Device Registration Certificate issued by the National Medical Products Administration for its hemodialysis concentrate.

The hemodialysis concentrate consists of two parts: Concentrate A and Concentrate B. Concentrate A is composed of sodium chloride (NaCl), potassium chloride (KCl), calcium chloride (CaCl2·2H2O), magnesium chloride (MgCl2·6H2O), glacial acetic acid (CH3COOH), and dialysis water. Concentrate B contains sodium bicarbonate (NaHCO3) and dialysis water.

The product is indicated for hemodialysis treatment of acute renal failure and chronic renal failure.

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/news/1133279062"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1133279062\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1133279062?lang=zh_TW&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-11-28 16:00","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1133279062","market":"us","top_or_hot":-1,"title":"Gansu Longshenrongfa Pharmaceutical (300534.SZ) Obtains Medical Device Registration Certificate for Hemodialysis Concentrate","media":"Stock News","content":"<p>Gansu Longshenrongfa Pharmaceutical (300534.SZ) announced that on November 28, 2025, the company received the Medical Device Registration Certificate issued by the National Medical Products Administration for its hemodialysis concentrate.</p>\n<p>The hemodialysis concentrate consists of two parts: Concentrate A and Concentrate B. Concentrate A is composed of sodium chloride (NaCl), potassium chloride (KCl), calcium chloride (CaCl2·2H2O), magnesium chloride (MgCl2·6H2O), glacial acetic acid (CH3COOH), and dialysis water. Concentrate B contains sodium bicarbonate (NaHCO3) and dialysis water.</p>\n<p>The product is indicated for hemodialysis treatment of acute renal failure and chronic renal failure.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Gansu Longshenrongfa Pharmaceutical (300534.SZ) Obtains Medical Device Registration Certificate for Hemodialysis Concentrate</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nGansu Longshenrongfa Pharmaceutical (300534.SZ) Obtains Medical Device Registration Certificate for Hemodialysis Concentrate\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036600163\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock News </p>\n<p class=\"h-time smaller\">2025-11-28 16:00</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p>Gansu Longshenrongfa Pharmaceutical (300534.SZ) announced that on November 28, 2025, the company received the Medical Device Registration Certificate issued by the National Medical Products Administration for its hemodialysis concentrate.</p>\n<p>The hemodialysis concentrate consists of two parts: Concentrate A and Concentrate B. Concentrate A is composed of sodium chloride (NaCl), potassium chloride (KCl), calcium chloride (CaCl2·2H2O), magnesium chloride (MgCl2·6H2O), glacial acetic acid (CH3COOH), and dialysis water. Concentrate B contains sodium bicarbonate (NaHCO3) and dialysis water.</p>\n<p>The product is indicated for hemodialysis treatment of acute renal failure and chronic renal failure.</p>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK0056","symbol_name":"扶貧","start_time":0,"source_url":"","article_id":"1133279062","we_media_id":"1036600163","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1133279062","pubTimestamp":1764316816,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Stock News","introduction":"Global Stock News First-Time Broadcast","home_visible":1,"id":"1036600163","head_image":"https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a"},"summary":"Gansu Longshenrongfa Pharmaceutical (300534.SZ) announced that on November 28, 2025, the company received the Medical Device Registration Certificate issued by the National Medical Products...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"159883":"医疗器械","300534":"陇神戎发","BK0056":"扶贫","09997":"康基医疗","BK1583":"高瓴概念","BK0239":"医药制造","BK1222":"医疗保健用品","BK0132":"高送转概念","BK1100":"医疗保健设备","09996":"沛嘉医疗-B","BK1574":"生物医药B类股"},"translate_title":"甘肃陇神荣发药业（300534.SZ）血液透析浓缩液获得医疗器械注册证","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"159883":1,"300534":1,"09996":1,"09997":1},"content_text":"Gansu Longshenrongfa Pharmaceutical (300534.SZ) announced that on November 28, 2025, the company received the Medical Device Registration Certificate issued by the National Medical Products Administration for its hemodialysis concentrate.\nThe hemodialysis concentrate consists of two parts: Concentrate A and Concentrate B. Concentrate A is composed of sodium chloride (NaCl), potassium chloride (KCl), calcium chloride (CaCl2·2H2O), magnesium chloride (MgCl2·6H2O), glacial acetic acid (CH3COOH), and dialysis water. Concentrate B contains sodium bicarbonate (NaHCO3) and dialysis water.\nThe product is indicated for hemodialysis treatment of acute renal failure and chronic renal failure.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"corporation","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"}}}